Approval · Notice of Compliance 2338 · 2001
IDAMYCIN: Notice of Compliance 2338
Issued May 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2338
- Date
- May 30, 2001
- Company
- Pharmacia Canada Inc.Baie D'Urfe, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic
Products in this notice
Medicinal ingredients
- IDARUBICIN HCL 5 MG per VIAL
- IDARUBICIN HCL 10 MG per VIAL
- IDARUBICIN HCL 5 MG per CAP
- IDARUBICIN HCL 10 MG per CAP
- IDARUBICIN HCL 25 MG per CAP